Benzinga - Fri, 19 Mar 2021 14:29:29 -0400
Benzinga - Wed, 10 Mar 2021 08:25:58 -0400
Benzinga - Wed, 10 Mar 2021 05:03:56 -0400
Benzinga - Tue, 09 Mar 2021 18:04:59 -0400
Benzinga - Tue, 09 Mar 2021 11:22:41 -0400
Benzinga - Tue, 09 Mar 2021 11:07:00 -0400
Benzinga - Tue, 09 Mar 2021 07:58:08 -0400
Benzinga - Sat, 06 Mar 2021 11:57:57 -0400
Benzinga - Fri, 05 Mar 2021 11:29:16 -0400
Benzinga - Fri, 05 Mar 2021 09:15:09 -0400
Benzinga - Fri, 05 Mar 2021 07:02:40 -0400
Benzinga - Fri, 05 Mar 2021 06:37:42 -0400
Benzinga - Thu, 04 Mar 2021 15:52:10 -0400
Benzinga - Thu, 04 Mar 2021 13:26:27 -0400
Benzinga - Thu, 04 Mar 2021 13:11:10 -0400
load more
Sector: Health Care.Industry: Biotechnology
Five Prime Therapeutics Inc is a biotechnology company focused on discovering and developing protein therapeutics for diseases. The company's product candidates address patient populations for which therapies are still needed. It is focused on advancing its internal pipeline and retaining rights for products in targeted specialty markets. It also seeks to establish additional collaborations to supplement its internal development capabilities. These collaborations generate additional funding in order to further validate the company's technology. It has the following product in the pipeline: Cabiralizumab, FPA150, FPT155, and Bemarituzumab.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-06
REV
Q4 2020Est.ActualSurprise
EPS-0.520-0.500 0.0200
REV3.270M-708.000K-3.978M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
FPRXFive Prime Therapeutics0.13%1.8B

Five Prime Therapeutics Company Questions & Answers

Q

How do I buy Five Prime Therapeutics (FPRX) stock?

A

You can purchase shares of Five Prime Therapeutics (NASDAQ: FPRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Five Prime Therapeutics's (FPRX) main competitors?

A

Other companies in Five Prime Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Zentalis Pharmaceuticals (NASDAQ:ZNTL) and FibroGen (NASDAQ:FGEN).

Q

What is the target price for Five Prime Therapeutics?

A

The latest price target for Five Prime Therapeutics (NASDAQ: FPRX) was reported by Guggenheim on 2021-03-09. The analyst firm set a price target for 38.00 expecting FPRX to rise to within 12 months (a possible 0.03% upside). 8 analyst firms have reported ratings in the last year.

Q

How much is Five Prime Therapeutics (FPRX) stock ?

A

The stock price for Five Prime Therapeutics (NASDAQ: FPRX) is $37.99 last updated Wed Apr 14 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Five Prime Therapeutics (FPRX) dividend?

A

There are no upcoming dividends for Five Prime Therapeutics.

Q

When is Five Prime Therapeutics (NASDAQ:FPRX) reporting earnings?

A
Five Prime Therapeutics’s Q1 earnings are confirmed after-market from now on May 6, 2021.
Q

When is the upcoming split for FPRX?

A

There is no upcoming split for Five Prime Therapeutics.